Vibeke Strand

3.7k total citations · 2 hit papers
14 papers, 2.2k citations indexed

About

Vibeke Strand is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, Vibeke Strand has authored 14 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 4 papers in Genetics and 4 papers in Hematology. Recurrent topics in Vibeke Strand's work include Rheumatoid Arthritis Research and Therapies (11 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Vibeke Strand is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Vibeke Strand collaborates with scholars based in United States, Canada and Netherlands. Vibeke Strand's co-authors include Peter Tugwell, John Kirwan, Peter Brooks, Michel Lequesne, Roy D. Altman, Nicholas Bellamy, Kenneth D. Brandt, M. Dougados, Maarten Boers and George A. Wells and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology and Arthritis & Rheumatism.

In The Last Decade

Vibeke Strand

14 papers receiving 2.1k citations

Hit Papers

Recommendations for a core set of outcome measures for fu... 1997 2026 2006 2016 1997 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vibeke Strand United States 13 1.6k 545 421 333 272 14 2.2k
J. M. W. Hazes Netherlands 27 2.1k 1.3× 599 1.1× 661 1.6× 235 0.7× 265 1.0× 61 3.1k
F C Breedveld Netherlands 28 1.3k 0.9× 390 0.7× 289 0.7× 237 0.7× 179 0.7× 74 2.4k
Jolanda J. Luime Netherlands 28 1.4k 0.9× 571 1.0× 360 0.9× 257 0.8× 170 0.6× 100 2.3k
G Kraag Canada 18 1.3k 0.8× 452 0.8× 214 0.5× 175 0.5× 180 0.7× 31 1.9k
D. van der Heijde Netherlands 22 2.7k 1.7× 828 1.5× 576 1.4× 403 1.2× 284 1.0× 36 3.2k
Carlo Alberto Scirè Italy 32 2.1k 1.3× 670 1.2× 431 1.0× 116 0.3× 333 1.2× 137 3.1k
Michel Zummer Canada 20 1.3k 0.8× 305 0.6× 209 0.5× 161 0.5× 241 0.9× 41 1.8k
M Dougados France 20 2.8k 1.8× 518 1.0× 1.0k 2.4× 736 2.2× 224 0.8× 36 3.8k
Violaine Foltz France 24 1.2k 0.8× 365 0.7× 300 0.7× 340 1.0× 211 0.8× 78 1.8k
A G Mowat United Kingdom 23 895 0.6× 230 0.4× 411 1.0× 209 0.6× 303 1.1× 90 2.0k

Countries citing papers authored by Vibeke Strand

Since Specialization
Citations

This map shows the geographic impact of Vibeke Strand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vibeke Strand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vibeke Strand more than expected).

Fields of papers citing papers by Vibeke Strand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vibeke Strand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vibeke Strand. The network helps show where Vibeke Strand may publish in the future.

Co-authorship network of co-authors of Vibeke Strand

This figure shows the co-authorship network connecting the top 25 collaborators of Vibeke Strand. A scholar is included among the top collaborators of Vibeke Strand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vibeke Strand. Vibeke Strand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Strand, Vibeke, Maarten Boers, Leanne Idzerda, et al.. (2011). It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.. The Journal of Rheumatology. 38(8). 1720–1727. 121 indexed citations
2.
Sokolove, Jeremy & Vibeke Strand. (2010). Rheumatoid arthritis classification criteria - It's finally time to move on!. PubMed. 68(3). 232–8. 12 indexed citations
3.
Tugwell, Peter, Maarten Boers, Vibeke Strand, et al.. (2009). OMERACT 9 ‒ 9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. The Journal of Rheumatology. 36(8). 1765–1768. 11 indexed citations
4.
Fleischmann, Roy, Jiří Vencovský, Ronald van Vollenhoven, et al.. (2008). Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Annals of the Rheumatic Diseases. 68(6). 805–811. 263 indexed citations
5.
Wells, George A., Jennifer J. Anderson, Maarten Boers, et al.. (2003). MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.. PubMed. 30(5). 1115–8. 28 indexed citations
6.
Wells, George A., Maarten Boers, Beverley Shea, et al.. (2003). MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.. PubMed. 30(5). 1110–1. 26 indexed citations
7.
Cohen, Stanley, Grant W. Cannon, Michael Schiff, et al.. (2001). Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis & Rheumatism. 44(9). 1984–1992. 216 indexed citations
8.
Beaton, Dorcas, Claire Bombardier, J.N. Katz, et al.. (2001). Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.. PubMed. 28(2). 400–5. 183 indexed citations
9.
Heijde, D. van der, Marissa Lassere, John Edmonds, et al.. (2001). Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.. PubMed. 28(4). 914–7. 25 indexed citations
10.
Strand, Vibeke, Peter Tugwell, Claire Bombardier, et al.. (1999). Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Arthritis & Rheumatism. 42(9). 1870–1878. 111 indexed citations
11.
Strand, Vibeke. (1999). Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate. Archives of Internal Medicine. 159(21). 2542–2542. 569 indexed citations breakdown →
12.
Boers, Maarten, Désirée van der Heijde, G S Alarcón, et al.. (1999). Imaging in rheumatoid arthritis: results of group discussions.. PubMed. 26(3). 749–51. 14 indexed citations
14.
Olsen, Nancy J., Raye H. Brooks, John J. Cush, et al.. (1996). A double‐blind, placebo‐controlled study of anti‐CD5 immunoconjugate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 39(7). 1102–1108. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026